Definium Therapeutics, Inc. Fair Value Adjustment of Warrants
Definium Therapeutics, Inc. (DFTX) reported Fair Value Adjustment of Warrants of $86.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-06
- Definium Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $86.23M, a 3770.33% increase year-over-year.
- Definium Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $20.05M.
- Definium Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $5.06M, a 4.20% increase year-over-year.
- Definium Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $22.55M.
- Definium Therapeutics, Inc. fair value adjustment of warrants for fiscal 2025 was $22.83M, a 43.22% increase from fiscal 2024.
- Definium Therapeutics, Inc. fair value adjustment of warrants for fiscal 2024 was $15.94M, a 140.22% increase from fiscal 2023.
- Definium Therapeutics, Inc. fair value adjustment of warrants for fiscal 2023 was $6.64M.
- Definium Therapeutics, Inc. fair value adjustment of warrants for fiscal 2022 was -$7.84M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $86.23M 10-Q · filed 2026-08-06 | $106.28M 10-Q · filed 2026-08-06 | $111.33M derived: sum of 3 quarters · filed 2026-08-06 | $133.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $20.05M 10-Q · filed 2026-05-07 | $25.10M derived: sum of 2 quarters · filed 2026-05-07 | $47.65M derived: sum of 3 quarters · filed 2026-05-07 | $49.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $27.60M derived: sum of 2 quarters · filed 2026-02-26 | $29.83M derived: sum of 3 quarters · filed 2026-08-06 | $22.83M 10-K · filed 2026-02-26 |
| 2025-09-30 | $22.55M 10-Q · filed 2025-11-06 | $24.77M derived: sum of 2 quarters · filed 2026-08-06 | $17.77M 10-Q · filed 2025-11-06 | $22.63M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.23M 10-Q · filed 2026-08-06 | -$4.77M 10-Q · filed 2026-08-06 | $82.00K derived: sum of 3 quarters · filed 2026-08-06 | -$8.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$7.00M 10-Q · filed 2026-05-07 | -$2.15M derived: sum of 2 quarters · filed 2026-05-07 | -$10.51M derived: sum of 3 quarters · filed 2026-05-07 | -$23.95M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.51M derived: sum of 2 quarters · filed 2026-02-26 | -$16.95M derived: sum of 3 quarters · filed 2026-02-26 | $15.94M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$8.36M 10-Q · filed 2025-11-06 | -$21.80M derived: sum of 2 quarters · filed 2025-11-06 | $11.09M 10-Q · filed 2025-11-06 | $14.05M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$13.45M 10-Q · filed 2025-07-31 | $19.45M 10-Q · filed 2025-07-31 | $22.41M derived: sum of 3 quarters · filed 2025-07-31 | $19.39M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $32.89M 10-Q · filed 2025-05-08 | $35.86M derived: sum of 2 quarters · filed 2025-05-08 | $32.84M derived: sum of 3 quarters · filed 2025-05-08 | $34.34M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$55.00K derived: sum of 2 quarters · filed 2025-03-06 | $1.45M derived: sum of 3 quarters · filed 2025-03-06 | $6.64M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$3.02M 10-Q · filed 2024-11-07 | -$1.52M derived: sum of 2 quarters · filed 2024-11-07 | $3.67M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.50M 10-Q · filed 2024-08-13 | $6.69M 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $5.18M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$7.84M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |